Sectors
Agent Capital, formed by Ex-Baxalta Ventures managing partner Geeta Vemuri, has raised $52m of a planned $150m for its first fund.
GE Ventures, Kaiser Permanente Ventures and existing backer Illumina Ventures have helped Genome Medical take its total funding to $23m
Grupo Sura returned to back a $42m series B round for MoneyLion, which has now secured a total of $67m in equity funding.
Oncology drug developer Genetron Health, which closed a Vcanbio-led series B round in 2016, has added $61.6m to its coffers.
The autonomous driving software developer, which also counts Nvidia as a backer, raised new funding from investors including Robert Bosch, Cisco and Samsung.
The partners intend to combine medical device maker LifeTech's expertise in China with ABG's global healthcare investment profile.
Didi Chuxing's reported $600m acquisition of a majority stake in its Brazilian counterpart indicates a new level to its expansion plans.
Terminus has bought BrightFunnel, a marketing analytics platform that had raised $9.5m from backers including Salesforce Ventures and Bloomberg Beta.
KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Ping An Ventures.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
